STIM

#3505
Neuronetics, Inc. - Common Stock
1.5 4 USD
-1.28%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
1.54
1.54
Range Annuel
0.80
4.82
Changement quotidien
-1.28%
Changement Mensuel
-9.41%
Evolution sur 6 mois
+3.36%
Changement Annuel
-60.71%
Clôture Précédente
1.5 6
Open
1.5 4
Low
1.5 4
High
1.5 4
Volume
33
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur 202020212022202320242025 TTM

Neuronetics, Inc. - Common Stock

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device." They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head.

Nouvelles